Indeed, many mechanisms of action have been proposed for its anti-cancer activity, such as the inhibition of the mitochondrial respiratory chain complex and the consequent activation of the AMPK pathway or the lowering of insulin and insulin-like growth factor 1 (IGF-1) levels, which reduce the activation of the PI3K/Akt/mTOR pathway. Here, MTOR is linked to cancer.